Related references
Note: Only part of the references are listed.Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq
Fengjin Hao et al.
LIFE SCIENCES (2021)
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
Mark E. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease
Hesam Khodadadi et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer's Disease Patients
Valerio Chiurchiu et al.
BIOMOLECULES (2021)
The short-term and long-term effects of cannabis on cognition: recent advances in the field
Emese Kroon et al.
CURRENT OPINION IN PSYCHOLOGY (2021)
Heavy cannabis use, dependence and the brain: a clinical perspective
Emese Kroon et al.
ADDICTION (2020)
Advances in Neurobiology and Pharmacology of GPR12
Gonzalo Allende et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report
Michaela Defrancesco et al.
FRONTIERS IN PSYCHIATRY (2020)
Cannabis knowledge and implications for health: Considerations regarding the legalization of non-medical cannabis
Luca Zamengo et al.
MEDICINE SCIENCE AND THE LAW (2020)
Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ1-42 peptide in rat hippocampal neurons
Zubeyir Elmazoglu et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Mitochondria and cellular redox state on the route from ageing to Alzheimer's disease
G. Abate et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer's Disease in a Preclinical Model: A Therapeutic Opportunity
Dina Medina-Vera et al.
BIOLOGY-BASEL (2020)
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
Timo Woelfl et al.
FRONTIERS IN PSYCHIATRY (2020)
Subchronic effects of ligands of cannabinoid receptors on learning and memory processes of olfactory bulbectomized rats
Margarita Velikova et al.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS (2020)
Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action
Giulia Abate et al.
HEALTHCARE (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation
Gabriela Aguilera-Portillo et al.
MOLECULAR NEUROBIOLOGY (2019)
Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review
Claire Gorey et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
New trends in cannabis potency in USA and Europe during the last decade (2008-2017)
Suman Chandra et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Rapamycin and Alzheimer's disease: Time for a clinical trial?
Matt Kaeberlein et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye et al.
CURRENT MOLECULAR PHARMACOLOGY (2019)
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
Nathan Herrmann et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease
David Schubert et al.
MOLECULAR NEUROBIOLOGY (2019)
Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells
Mikiei Tanaka et al.
CELLS (2019)
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
Hery Chung et al.
PLOS ONE (2019)
Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory
Ren-shi Li et al.
SCIENTIFIC REPORTS (2019)
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment
Serena Montanari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35
Aleidy Patricio-Martinez et al.
NEUROSCIENCE (2019)
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Matthias Scheiner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability
Wilfrid Mazier et al.
MOLECULAR METABOLISM (2019)
Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation
Jeremy D. Hill et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits et al.
PAIN AND THERAPY (2019)
Delta-9-Tetrahydrocannabinol (a†9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats
Noor Azuin Suliman et al.
NEUROTOXICITY RESEARCH (2018)
Possible role of hippocampal GPR55 in spatial learning and memory in rats
Bruno A. Marichal-Cancino et al.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS (2018)
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes-Resina et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease
Alberto Llorente-Ovejero et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory
Laurie M. Robin et al.
NEURON (2018)
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation
Patrizia Ratano et al.
NEUROPHARMACOLOGY (2018)
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
Sara Anna Bonini et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
Soraya Wilke Saliba et al.
JOURNAL OF NEUROINFLAMMATION (2018)
One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory
Randi Melissa Schuster et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Verbal Memory Performance and Reduced Cortical Thickness of Brain Regions Along the Uncinate Fasciculus in Young Adult Cannabis Users
Nina Levar et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Deficits in striatal dopamine release in cannabis dependence
E. van de Giessen et al.
MOLECULAR PSYCHIATRY (2017)
Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia
Daniel G. Amen et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
High-Dose Cannabidiol Induced Hypotension after Global Hypoxia-Ischemia in Piglets
Havard T. Garberg et al.
NEONATOLOGY (2017)
Cannabis-associated psychosis: Neural substrate and clinical impact
R. M. Murray et al.
NEUROPHARMACOLOGY (2017)
The effects of synthetic cannabinoids on executive function
K. Cohen et al.
PSYCHOPHARMACOLOGY (2017)
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum
A. Musella et al.
SCIENTIFIC REPORTS (2017)
Cannabidiol, a novel inverse agonist for GPR12
Kevin J. Brown et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
GPR3 and GPR6, novel molecular targets for cannabidiol
Alyssa S. Laun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells
Rosaliana Libro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats
Marisol Maya-Lopez et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
Samantha J. Broyd et al.
BIOLOGICAL PSYCHIATRY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
FAAH inhibitors in the limelight, but regrettably
Christophe Mallet et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
Assaf Shelef et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Phytocannabinoids: a unified critical inventory
Lumir Ondrej Hanus et al.
NATURAL PRODUCT REPORTS (2016)
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence
M. Barbieri et al.
NEUROPHARMACOLOGY (2016)
ASTROGLIAL TYPE-1 CANNABINOID RECEPTOR (CB1): A NEW PLAYER IN THE TRIPARTITE SYNAPSE
J. F. Oliveira Da Cruz et al.
NEUROSCIENCE (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
Yong Li et al.
NEURAL PLASTICITY (2016)
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
Antonio Currais et al.
NPJ AGING AND MECHANISMS OF DISEASE (2016)
The role of cannabinoids in adult neurogenesis
Jack A. Prenderville et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
Rea Pihlaja et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission
Jimok Kim et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Age-related changes in the endocannabinoid system in the mouse hippocampus
Anastasia Piyanoya et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
Amir I. A. Ahmed et al.
PSYCHOPHARMACOLOGY (2015)
Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models
Yunhong Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
Alena V. Savonenko et al.
PLOS ONE (2015)
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
N. A. Balenga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cannabinoid Effects on beta Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
Emelie Janefjord et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
Simone Tambaro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: Modulation by cannabinoid agonists
A. C. Pascual et al.
EXPERIMENTAL GERONTOLOGY (2014)
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice
Balapal S. Basavarajappa et al.
HIPPOCAMPUS (2014)
The Potential Therapeutic Effects of THC on Alzheimer's Disease
Chuanhai Cao et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
David Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Ultralow Doses of Cannabinoid Drugs Protect the Mouse Brain From Inflammation-Induced Cognitive Damage
Miriam Fishbein-Kaminietsky et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Synthetic cannabinoids: Analysis and metabolites
Mahmoud A. ElSohly et al.
LIFE SCIENCES (2014)
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model
Wayne B. Anderson et al.
NEUROPHARMACOLOGY (2014)
Astrocytes in endocannabinoid signalling
Marta Navarrete et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
What we know and do not know about the cannabinoid receptor 2 (CB2)
Anna Maria Malfitano et al.
SEMINARS IN IMMUNOLOGY (2014)
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
Jeremy Koppel et al.
MOLECULAR MEDICINE (2014)
Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling
Rongqing Chen et al.
CELL (2013)
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
Maria J. Casarejos et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-β Neurotoxicity
Marie E. Benoit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold
Viktor Rempel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Jiang Wu et al.
NEUROBIOLOGY OF AGING (2013)
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
Chia-Shan Wu et al.
PLOS ONE (2013)
Cannabinoid Receptor CB2 Modulates Axon Guidance
Gabriel Duff et al.
PLOS ONE (2013)
GPR3 Stimulates Aβ Production via Interactions with APP and β-Arrestin2
Christopher D. Nelson et al.
PLOS ONE (2013)
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
Leigh V. Panlilio et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacological effects of cannabinoids on the reference and working memory functions in mice
Avdesh Avdesh et al.
PSYCHOPHARMACOLOGY (2013)
Effect of long-term cannabis use on axonal fibre connectivity
Andrew Zalesky et al.
BRAIN (2012)
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling
Javier Palazuelos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Serum response factor modulates neuron survival during peripheral axon injury
Sina Stern et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
Norbert Zilka et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Cannabinoids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Barbara Todaro
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
Kwang-Mook Jung et al.
NEUROBIOLOGY OF AGING (2012)
The endocannabinoid system in normal and pathological brain ageing
Andras Bilkei-Gorzo
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Anxiogenic-like effects of chronic cannabidiol administration in rats
Maha M. ElBatsh et al.
PSYCHOPHARMACOLOGY (2012)
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
Justin R. Piro et al.
CELL REPORTS (2012)
Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
Rongqing Chen et al.
CELL REPORTS (2012)
The Genetics of Alzheimer Disease
Rudolph E. Tanzi
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease
Jan Mulder et al.
BRAIN (2011)
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55
Eyangelia Kotsikorou et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2011)
Cannabinoids Alter Spontaneous Firing, Bursting, and Cell Synchrony of Hippocampal Principal Cells
Anushka V. Goonawardena et al.
HIPPOCAMPUS (2011)
Dysfunctional Prefrontal Cortical Network Activity and Interactions following Cannabinoid Receptor Activation
Michal T. Kucewicz et al.
JOURNAL OF NEUROSCIENCE (2011)
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Douglas S. Johnson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Dysregulation of mTOR Signaling in Fragile X Syndrome
Ali Sharma et al.
JOURNAL OF NEUROSCIENCE (2010)
Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
Ying Gao et al.
JOURNAL OF NEUROSCIENCE (2010)
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
Jasinda H. Lee et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
Asami Tanimura et al.
NEURON (2010)
Chronic use of cannabis and poor neural efficiency in verbal memory ability
Robert A. Battisti et al.
PSYCHOPHARMACOLOGY (2010)
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
Yannick Marchalant et al.
NEUROBIOLOGY OF DISEASE (2009)
Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol
Laura E. Wise et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
Jonathan Z. Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regional brain abnormalities associated with long-term heavy cannabis use
Murat Yuecel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
K. L. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner
Maria Beatriz Goncalves et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory
Julia R. Clarke et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review
Ivana Svizenska et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain
Maulik D. Jhaveri et al.
MOLECULAR NEUROBIOLOGY (2007)
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats
L. Robinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task
Stephen A. Varvel et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
G. T. Whiteside et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
Javier Palazuelos et al.
FASEB JOURNAL (2006)
A molecular link between the active component of marijuana and Alzheimer's disease pathology
Lisa M. Eubanks et al.
MOLECULAR PHARMACEUTICS (2006)
CB, receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
Endocannabinoids and β-amyloid-induced neurotoxicity in vivo:: effect of pharmacological elevation of endocannabinoid levels
M. van der Stelt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
S Walther et al.
PSYCHOPHARMACOLOGY (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
W Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
A Bilkei-Gorzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
The endocannabinoid system drives neural progenitor proliferation
T Aguado et al.
FASEB JOURNAL (2005)
In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Δ9-tetrahydrocannabinol
E Butovsky et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain:: An immunohistochemical study
E Núñez et al.
SYNAPSE (2004)
Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice
KL Jin et al.
MOLECULAR PHARMACOLOGY (2004)
Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo
MN Hill et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats
M Schneider et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Therapeutic potential of cannabinoids in CNS disease
JL Croxford
CNS DRUGS (2003)
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
TP Dinh et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors
K Uhlenbrock et al.
CELLULAR SIGNALLING (2002)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
RI Wilson et al.
NATURE (2001)
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats
D Braida et al.
NEUROREPORT (2000)
Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons
N Auclair et al.
JOURNAL OF NEUROPHYSIOLOGY (2000)
Share Paper
